Evidence map›Paper›PMID 30120297›Full record

ArticleScientific reports2018

COMP-Angiopoietin-1 accelerates muscle regeneration through N-cadherin activation.

Seock-Won Youn, Hyun-Chae Lee, Sae-Won Lee, Jaewon Lee, Hyunduk Jang, Eun Ju Lee, Hyo-Soo Kim

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Newly-engineered angiopoietin-1 as a cell-priming agent for CVD.Cellular and molecular life sciences : CMLS · 2025
    Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Seock-Won YounCenter of Cell- & Bio-Therapy for Heart, Diabetes, and Cancer, Seoul National University Hospital, Seoul, Korea.
Hyun-Chae LeeCenter of Cell- & Bio-Therapy for Heart, Diabetes, and Cancer, Seoul National University Hospital, Seoul, Korea.
Sae-Won LeeDepartment of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea.
Jaewon LeeCenter of Cell- & Bio-Therapy for Heart, Diabetes, and Cancer, Seoul National University Hospital, Seoul, Korea.ORCID 0000-0002-9400-5384
Hyunduk JangDepartment of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea.
Eun Ju LeeDepartment of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea.
Hyo-Soo KimCenter of Cell- & Bio-Therapy for Heart, Diabetes, and Cancer, Seoul National University Hospital, Seoul, Korea. hyosoo@snu.ac.kr.
Seoul National University · KRSeoul National University Hospital · KRSeoul National University of Science and Technology · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Angiopoietin-1 modulates vascular stability via Tie2 on endothelial cells. In our previous study, we also showed it acts as an inhibitor of cardiomyocyte death. However, it remains poorly understood how Ang1 regulates myogenesis during muscle regeneration. Here we found that COMP-Ang1 (cAng1) enhances muscle regeneration through N-cadherin activation. Muscle fiber regeneration after limb muscle damage by ischemic injury was enhanced with cAng1 treatment. Mechanistically cAng1 directly bound to N-cadherin on the myoblast surface in a Ca

Indexed as

Muscle DevelopmentRegenerationAngiopoietin-1AnimalsCadherinsCartilage Oligomeric Matrix ProteinCateninsCell DifferentiationDelta CateninGene ExpressionIschemiaMiceModels, BiologicalMuscle Fibers, SkeletalMyoblastsMyogeninAngiopoietin-1CadherinsCartilage Oligomeric Matrix ProteinCateninsCtnnd1 protein, mouseDelta CateninMyogeninp38 Mitogen-Activated Protein Kinases

Identifiers

PMID30120297
PMCPMC6098079
OpenAlexW2887097001

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.